Locally Advanced Renal Pelvis Urothelial Carcinoma

7 clinical trials · Condition

Record	Firm	Date
Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer (NCT07667335)	Fred Hutchinson Cancer Center	2026-12-01
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)	National Cancer Institute (NCI)	2022-07-07
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594)	Alliance for Clinical Trials in Oncology	2022-05-27
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)	M.D. Anderson Cancer Center	2021-09-23
ARID1A and/or KDM6A Mutation and CXCL13 Expression (NCT04953104)	M.D. Anderson Cancer Center	2021-09-21
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519)	Emory University	2021-05-20
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780)	National Cancer Institute (NCI)	2018-07-20

Every clearance here is in the API, with alerts when new ones post.